Felipe Prósper Cardoso
Director of the Cell Therapy Area
Co-director of the Hematology and Hemotherapy Service.
Clinical University of Navarre
Spain
Biography
Graduate (1988) and Doctor (1994) in Medicine by the University of Navarra. Specialist in Hematology and Hemotherapy by the University of Navarra Clinic. He completed his training with a fellowship in Hematology and Oncology at the University of Minnesota (1997) Director of the Cell Therapy Area and co-director of the Hematology Service at the Clínica Universidad de Navarra. Research Areas Member of the editorial board of 15 national and international scientific journals. Evaluator for National Evaluation and Prospective Agency (ANEP) from 1999 to the present. Evaluator of the Junta de Andalucía from 2006 to the present. Expert Evaluator of Research Projects in the European Union from 2007 to the present. Coordinator of the Area of ​​Oncology and Hematology and member of the Internal Scientific Committee of the Institute of Sanitary Research of Navarre. Appointed by the Government of Navarre (Department of Health) February 11, 2014. Chairman of the Research Commission of the University of Navarra Clinic. From January 2014 until today. He has conducted more than 30 clinical trials as a principal investigator. He has directed more than 50 research projects, obtaining funding from institutions such as FIS, Ministry of Science and Technology, European projects and private institutions. Positive evaluation (Sexenios). Advisory Committee of the National Commission Evaluating the Research Activity. Application for Evaluation of the period 1996-2013. Date: June 18, 2014 ACTIVITY As a teacher Accredited Professor Contractor Doctor and Professor of Private University at the University of Navarra by the ANECA in 2007, and Professor of Medicine - University in 2009. He has conducted 21 doctoral theses, all with the highest qualification and 2 extraordinary awards. As researcher He has given more than 260 invited papers, organized and moderate sessions in national and international congresses. He has published more than 220 articles in national and international magazines. He has published 24 chapters of national and international books He has presented more than 190 communications to national and international congresses.
Research Interest
Study of the diagnosis and treatment of: Myelomas Chronic myeloproliferative syndromes Leukemias It develops a research program and clinical application in cell therapy with adult stem cells, promoting several lines of research, focused mainly on the use of stem cells for the treatment of cardiovascular, osteoarticular and immune diseases. At the same time, it maintains and develops a line of research in the mechanisms of epigenetic control in hematological malignancies and healthy stem cells, directed to investigate the role of these mechanisms in the regulation of autorrenovation and differentiation.